Advertisement

Experimental Basis of Cancer Chemotherapy

  • Norbert Brock

Abstract

In the course of its 30 years of development, chemotherapy has acquired a firm place in the treatment of human cancer in addition to the classical methods of surgery and radiation therapy, which have been of considerable benefit in fighting primary tumours. By their very nature, surgery and radiation therapy are local or regional measures. By the time of diagnosis more than two thirds of all malignant tumours have spread beyond their local borders so that therapeutic benefit can only be expected from additional systemic treatment and therefore chemotherapy has its preferential potentialities in such generalized tumour conditions. This conclusion invariably applies irrespective of whether the present drugs are satisfactory or not.

Keywords

Cancer Chemotherapy Experimental Basis Primary Screening Nitrogen Mustard Transport Form 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Arnold, H., Bourseaux, F., Brock, N. Naturwiss 45, 64 (1958).CrossRefGoogle Scholar
  2. 2.
    Arnold, H., Bourseaux, F., Brock, N. Drug Res. 11, 143, (1961).Google Scholar
  3. 3.
    Brock, N. vth Int. Congress of Chemotherapy, Vol 11/1, 1967 p.155.Google Scholar
  4. 4.
    Brock, N. Med. Mschr. 27, 390 (1973)PubMedGoogle Scholar
  5. 5.
    Brock, N. Symposium Chester Beatty Research Institute, London July 1975.Google Scholar
  6. 6.
    Brock, N., Geks, F.J. Naturwiss, 38, 351, (1951).CrossRefGoogle Scholar
  7. 7.
    Brock, N., Hohorst, H.J. Drug Research 13, 1021 (1963).PubMedGoogle Scholar
  8. 8.
    Brock, N., Schneider, B. Drug. Res. 11, 1, (1961).Google Scholar
  9. 9.
    Brock, N., Schneider, B. Drug Res. 14, 171 (1964).Google Scholar
  10. 10.
    Brock, N., Schneider, B. Drug Res. 21, 435 (1971).Google Scholar
  11. 11.
    Brock, N., Wilmanns, H. Dtsch. med. Wschr. 83, 453 (1958).PubMedCrossRefGoogle Scholar
  12. 12.
    Calendi, E., DiMarco, A., Reggiani, M. et al. Biochem. Biophys. Acta 103, 25 (1965).PubMedGoogle Scholar
  13. 13.
    Connors, T.A., Cox, P.J., Farmer, P.B., Foster, A.G., Jarman, M. Biochem. Pharmacol. 23 115 (1974).PubMedCrossRefGoogle Scholar
  14. 14.
    DiMarco, A. in: Heffter-Heubner:Handbuch der experimentellen Pharmakologie, Vol XXXVIII/2, p. 593. Springer 1975 Berlin-Heidelberg-New York.Google Scholar
  15. 15.
    Bruckrey, H. Dtsch. med. Wschr. 77 1495 + 1534 (1952).Google Scholar
  16. 16.
    Bruckrey, H., Preussmann, R., Ivankovic, S., Schmahl, D. Z. Krebsforsch. 69, 103 (1967).CrossRefGoogle Scholar
  17. 17.
    Bruckrey, H., Steinhoff, D., Nakayama, M., Preussmann, R., Anger, K. Dtsch. med. Wschr. 88, 651 (1963).CrossRefGoogle Scholar
  18. 18.
    Goldin, A., Serpick, A.A., Mantel, N. Cancer Chemother. Rep. 50, 173 (1966).PubMedGoogle Scholar
  19. 19.
    Goldin, A., Venditti, J.M., Mantel, N. In:Heffter-Heubner Handbuch der experimentellen Pharmakologie Vol XXXVIII/1, p. 411. Springer 1974, Berlin, Heidelberg, New York.Google Scholar
  20. 20.
    Hartwich, G., Fachs, H.F. Heidhardt, B. Fortschr, Med. 90, 46, (1972).Google Scholar
  21. 21.
    Hoefer-Janker, H., Scheef, W., Gunther, U., Huls, W. Med. Welt 26, 972 (1975).PubMedGoogle Scholar
  22. 22.
    Hohorst, H.J., Draeger, U. Peter, G., Voelcker, G. Symposium Chester Beatty Research Institute, London July 1975.Google Scholar
  23. 23.
    Ivankovic, S., Zeller, W.J. Blut 28, 288 (1974).PubMedCrossRefGoogle Scholar
  24. 24.
    Klein, H.O., Lennartz, R.J., Gross, R., Eder, M., Fischer, R. Dtsch. med. Wschr. 97 1273 (1972).PubMedCrossRefGoogle Scholar
  25. 25.
    Korner, F., Lund, S., Jonas, U. Munch, med. Wschr (in press)Google Scholar
  26. 26.
    Larionov, L.F. Cancer Chemother. Rep. Part 1, 54, 71 (1970).Google Scholar
  27. 27.
    Norpoth, K. 9th Int. Congress of Chemotherapy London July 1975.Google Scholar
  28. 28.
    Potel, J., Brock, N. Z. Rheumaforsch. 31, Supp 2., 339 (1972).Google Scholar
  29. 29.
    Schadel, F.M.Jr., Johnston, T.P., McCales, G.S., Montgomery, J.A., Laster, W.R., Skipper, H.E. Cancer Res. 23, 725 (1965).Google Scholar
  30. 30.
    Schabel, F.M. Jr., Skipper, H.E., Trader, M.W., Laster, W.R. Jr., Cheeks, J.B. Cancer Chemother. Rep. 4, 53 (1974).Google Scholar
  31. 31.
    Voelcker, G., Draeger, U., Peter, G., Hohorst, H.J. Arzneim.-Forsch. (Drug Res.) 24, 1172 (1974).Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Norbert Brock
    • 1
  1. 1.Chemische FabrikAsta-Werke A.G.Bielefeld 14, BrackwedeWest Germany

Personalised recommendations